Dermatology Doctors in Jonesboro, AR Accepting Medicare

5 Dermatology doctors found. Showing 1 - 5

Dr. Zachary Paul Nahmias, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4910 Medical Blvd, Jonesboro, AR 72405 Phone: 870-936-8000    Fax: 870-934-3623

Dr. Colton Nielson, MD, FAAD, ACMS Dermatology Medicare: Accepting Medicare Assignments Practice Location: 800 S Church St Ste 103, Jonesboro, AR 72401 Phone: 870-333-5145

Dr. Mallory Hurst, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 800 S Church St Ste 202, Jonesboro, AR 72401 Phone: 870-336-0277    Fax: 870-932-5699

David Howard Weingold, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 4334 E Highland Dr, Jonesboro, AR 72401 Phone: 870-802-3376    Fax: 870-972-5140

Dr. Adam Ashley Sills, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1003 Windover Rd, Jonesboro, AR 72401 Phone: 870-336-1600    Fax: 870-336-0585

News Archive

Oral delivery of PYY hormone can help obese people lose weight

Most people understand that serious weight loss requires changing attitudes toward what they eat and how often they exercise. But, what if the process could be aided by simply chewing a stick of gum after meals? That's the question a team of scientists, led by Syracuse University chemist Robert Doyle, is trying to answer. In a groundbreaking new study, Doyle's team demonstrated, for the first time, that a critical hormone that helps people feel "full" after eating can be delivered into the bloodstream orally.

Not all good cholesterol helps to protect arteries from becoming clogged with fatty deposits

HDL becomes dysfunctional, Dr. Hazen said, when myeloperoxidase (MPO), an enzyme present in white blood cells, inhibits the HDL's ability to keep LDL, or "bad" cholesterol, from building up in artery walls.

Cancer treatment does not affect pregnancy outcome, shows new study

Women who are pregnant when diagnosed with cancer can start treatment for their disease immediately and do not need to terminate their pregnancy due to worries over the effects of therapy on the development of their child.

NovaSterilis reports significant findings from sterilization of absorbable suture study

NovaSterilis Inc. a leader in the development and commercialization of supercritical carbon dioxide (SCCO2) technology in collaboration with CC Chu Ph.D (Cornell) reports successful findings from research funded by a National Institutes of Health (NIH) phase l grant. These results meet the study goal to sterilize absorbable sutures to a sterility assurance level 10-6 (SAL6) without chemical or mechanical degradation. NovaSterilis intends to apply for phase II funding to develop the process ready for commercial application.

UFCW opposes Whole Foods CEO John Mackey's efforts to undermine meaningful health care reform

In response to a recent Wall Street Journal op-ed by Whole Foods' Chief Executive Officer John Mackey, activists, consumers and labor groups around the country have been organizing in opposition to his efforts to undermine meaningful health care reform.

Read more Medical News

› Verified 1 days ago